Home Stock

Stock Research: Granules India

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Granules India

NSI:GRANULES INE101D01020
68
  • Value
    48
  • Growth
    80
  • Safety
    Safety
    29
  • Combined
    46
  • Sentiment
    16
  • 360° View
    360° View
    68
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Granules India Limited is an India-based pharmaceutical manufacturing company. It operates in pharmaceutical products, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs), and finished dosages, and owns Senn Chemicals AG, a CDMO specializing in peptide development and manufacturing. The company sells its products in global markets, including India, the United States of America, Canada, Latin America, Europe, and Asia Pacific. In the last fiscal year, the company had a market cap of $1410 million, profits of $323 million, and revenue of $524 million.

more

ANALYSIS: With an Obermatt 360° View of 68 (better than 68% compared with alternatives), overall professional sentiment and financial characteristics for the stock Granules India are above average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Granules India. The consolidated Growth Rank has a good rank of 80, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. It ranks higher than 80% of competitors in the same industry. The other indicators are below average, namely the Value, Safety, and Sentiment Ranks.The Value Rank at 48 means that the share price of Granules India is on the high side compared with its peers regarding revenues, profits, and invested capital. The stock price is higher than for 52% of alternative stocks in the same industry. The consolidated Safety Rank has a riskier rank of 29, which means that the company has a riskier financing structure than 71% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. The consolidated Sentiment Rank also has a low rank of 16, indicating professional investors are more pessimistic about the stock than for 84% of alternative investment opportunities. ...read more

more
Strongest Rank Market Pulse
Weakest Rank Revenue Growth
Country India
Industry Pharmaceuticals
Size Medium
Website granulesindia.com
Index
Granules India stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
48 47 65 73
Growth
80 73 69 23
Safety
Safety
29 15 31 47
Sentiment
16 77 67 4
360° View
360° View
68 59 72 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
69 95 95 20
Opinions Change
10 72 11 50
Pro Holdings
n/a 70 67 42
Market Pulse
3 22 46 29
Sentiment
16 77 67 4
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
48 47 65 73
Growth
80 73 69 23
Safety Safety
29 15 31 47
Combined
46 33 63 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
54 60 82 78
Price vs. Earnings (P/E)
64 62 86 74
Price vs. Book (P/B)
49 53 73 67
Dividend Yield
31 12 10 36
Value
48 47 65 73
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
88 80 72 72
Profit Growth
40 69 32 8
Capital Growth
65 27 80 45
Stock Returns
77 79 55 27
Growth
80 73 69 23
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
25 30 32 36
Refinancing
35 36 46 58
Liquidity
50 32 48 55
Safety Safety
29 15 31 47

Similar Stocks

Discover high‑ranked alternatives to Granules India and broaden your portfolio horizons.

Kalbe Farma

JKT:KLBF
Country: Indonesia
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

SBI Life Insurance

NSI:SBILIFE
Country: India
Industry: Life & Health Insurance
Size: Large
Full Stock Analysis

Mega Lifesciences

SET:MEGA
Country: Thailand
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

CESC

NSI:CESC
Country: India
Industry: Electric Utilities
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

The only positive is high growth. The stock is expensive (low Value Rank), risky to finance, and carries critical professional sentiment. This is a risky proposition. Avoid unless you have exceptional conviction that the growth alone will overcome the price and financial risks.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews